Frazier Life Sciences Management’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.1M | Hold |
|
|||||
|
2025
Q1 | $15.4M | Hold |
|
|||||
|
2024
Q4 | $22M | Hold |
|
|||||
|
2024
Q3 | $18.7M | Hold |
|
|||||
|
2024
Q2 | $154M | Buy |
|
|||||
|
2024
Q1 | $163M | Hold |
|
|||||
|
2023
Q4 | $157M | Hold |
|
|||||
|
2023
Q3 | $132M | Hold |
|
|||||
|
2023
Q2 | $168M | Hold |
|
|||||
|
2023
Q1 | $162M | Buy |
|
|||||
|
2022
Q4 | $163M | Hold |
|
|||||
|
2022
Q3 | $167M | Buy |
|
|||||
|
2022
Q2 | $101M | Buy |
|